Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 4

1(14.3%)

Phase 2

1(14.3%)

7Total

N/A(5)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06724965Not ApplicableNot Yet Recruiting

Trans STAIR: Implementing an Evidence Based Trauma Treatment With Community Led PrEP Navigation

Role: collaborator

NCT03205696Completed

Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection

Role: collaborator

NCT06181916Not ApplicableUnknown

Quantitative and Qualitative Research for "mHealth Program to Support People Living With HIV Across the HIV Care Continuum"

Role: collaborator

NCT03191474Not ApplicableCompleted

Linkage of Transgender Individuals to PrEP

Role: collaborator

NCT03086200Not ApplicableCompleted

Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals

Role: collaborator

NCT01781806Phase 4Completed

A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services

Role: collaborator

NCT00949234Phase 2Completed

Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV

Role: collaborator

NCT02257658Not ApplicableCompleted

Efficacy of Doxycycline Prophylaxis to Reduce Syphilis in High-Risk, HIV-Positive MSM

Role: lead

All 8 trials loaded